0
0

Chapter 13. Neurobiology of Hallucinogens

Richard A. Glennon, Ph.D.
DOI: 10.1176/appi.books.9781585623440.347177

Sections

Excerpt

Hallucinogenic agents represent an old and very large class of drugs. Nearly every major civilization throughout history has had a preferred drug of abuse or mind-altering substance. In some instances these have been hallucinogens or hallucinogen-related agents or plant products. Various agents can produce hallucinogenic episodes, and terms used to describe such agents include hallucinogens, psychotomimetics, psychedelics, inebriants,and intoxicants. Many agents can be found in this general class of psychoactive agents. More recently, certain hallucinogens have been included in the loose collection of agents termed club drugs, party drugs, or rave drugs. It is clear, however, that membership in these latter categories is not pharmacologically based and that most agents bearing this appellation are not hallucinogens. Do agents as structurally diverse as (+)lysergic acid diethylamide ([+]LSD), phencyclidine (PCP, angel dust), tetrahydrocannabinol (THC; a constituent of marijuana), amphetamine, and mescaline all produce the same (or a common) effect? Do they all work via a common pharmacological mechanism? Studies conducted over the past several decades indicate they do not (see Glennon 2002 for a review).

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

+

CME Activity

Add a subscription to complete this activity and earn CME credit.
Sample questions:
1.
One problem in classifying hallucinogens has been a sufficiently rigorous, specific, and inclusive definition of these chemically heterogeneous substances. An early set of criteria was produced by Hollister (1968). Which of the following is not characteristic of hallucinogens, according to these criteria?
2.
According to the definition of classical hallucinogen, which serotonin receptor is the target of drug binding?
3.
Various chemical compounds meet the criteria for definition as classical hallucinogens. Several of these are classified as indolealkylamines or phenylalklyamines. Which of the following compounds is a phenylalklyamine?
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 15.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 14.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 49.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 50.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 51.  >
Topic Collections
Psychiatric News
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation